Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

Patricia holds her Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She also served as a PhD student research assistant in the Laboratory of Doctor David A. Fidock, Department of Microbiology & Immunology, Columbia University, New York.

May 18, 2017May 18, 2017

Memory T-Cells Contribute to Body’s Naturally Acquired Immunity Against Pneumonia During Childhood, Study Suggests

A key immune system component called memory T-cells contributes to the naturally occurring protection against pneumonia-causing bacteria that the body develops during childhood, according to a study. The research, “Regionally compartmentalized ... Read more

April 27, 2017April 27, 2017

Murepavadin Works Against Antibiotic-Resistant Pneumonia, Study Shows

Polyphor‘s Murepavadin eliminated antibiotic-resistant bacteria in 11 of 12 pneumonia patients who took it, according to a small study the company conducted. That finding was part of a presentation the Swiss ... Read more

January 12, 2017January 13, 2017

A Number of Other Bacteria Found in Lungs of Legionella-pneumonia Patients, Study Shows

Sputum samples of patients hospitalized with Legionella-infected pneumonia contained a number of other bacteria and pathogens, researchers using a novel detection technique called Next Generation Sequencing have found. The study, “Comparison ... Read more

January 3, 2017January 3, 2017

Women at Higher Risk for Pneumonia Linked to Drug-resistant Pathogens, Study Finds

Several risks factors have been identified as increasing the likelihood of immunocompetent patients developing pneumonia tied to drug-resistant pathogens. Female sex was reported to be a dominant risk factor, followed by a recent hospitalization. The ... Read more

July 19, 2016

Adempas (riociguat) Not Recommended for PH-IIP Patients After Study Halted, EMA Says

The European Medicines Agency (EMA) recently recommended that Adempas (riociguat) should not be used by patients with symptomatic pulmonary hypertension associated with idiopathic interstitial pneumonia (PH-IIP). The recommendation was issued after the early ... Read more

May 12, 2016May 20, 2016

Risk Factors for Pneumonia Identified in Large Taiwan Population of Parkinson’s Patients

A large Taiwan population-based cohort study identified several risk factors, including chronic heart failure, chronic kidney disease, and tooth decay, associated with increased hospitalization of Parkinson’s disease patients due to pneumonia. The ... Read more

May 11, 2016May 12, 2016

Resistant Staphylococcus aureus Causing Community-acquired Pneumonia Needs Novel Diagnostics Strategy, Study Shows

In a new study, researchers highlighted the need for new diagnostic strategies to effectively distinguish between susceptible and resistant Staphylococcus aureus causing community-acquired pneumonia (CAP), so that effective antibiotic therapies are properly ... Read more